SE9900211D0 - New compounds - Google Patents

New compounds

Info

Publication number
SE9900211D0
SE9900211D0 SE9900211A SE9900211A SE9900211D0 SE 9900211 D0 SE9900211 D0 SE 9900211D0 SE 9900211 A SE9900211 A SE 9900211A SE 9900211 A SE9900211 A SE 9900211A SE 9900211 D0 SE9900211 D0 SE 9900211D0
Authority
SE
Sweden
Prior art keywords
alkyl
substituted
aryl
substituted aryl
nhr9
Prior art date
Application number
SE9900211A
Other languages
English (en)
Swedish (sv)
Inventor
Charles Hedgecock
Eric Desarbre
Guido Kurz
Martin Norin
Marguerite Luthman
Cathrin Widerstaahl
Original Assignee
Pharmacia & Upjohn Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia & Upjohn Ab filed Critical Pharmacia & Upjohn Ab
Priority to SE9900211A priority Critical patent/SE9900211D0/xx
Publication of SE9900211D0 publication Critical patent/SE9900211D0/xx
Priority to PCT/SE2000/000144 priority patent/WO2000043387A1/en
Priority to ES00902282T priority patent/ES2202045T3/es
Priority to AU23406/00A priority patent/AU760346B2/en
Priority to US09/490,232 priority patent/US6329383B1/en
Priority to PT00902282T priority patent/PT1155014E/pt
Priority to AT00902282T priority patent/ATE242237T1/de
Priority to NZ512597A priority patent/NZ512597A/en
Priority to SI200030180T priority patent/SI1155014T1/xx
Priority to DE60003158T priority patent/DE60003158T2/de
Priority to JP2000594803A priority patent/JP2002535325A/ja
Priority to DK00902282T priority patent/DK1155014T3/da
Priority to CA002359107A priority patent/CA2359107A1/en
Priority to EP00902282A priority patent/EP1155014B1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Rheumatology (AREA)
  • Diabetes (AREA)
  • Dermatology (AREA)
  • Neurology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
SE9900211A 1999-01-25 1999-01-25 New compounds SE9900211D0 (sv)

Priority Applications (14)

Application Number Priority Date Filing Date Title
SE9900211A SE9900211D0 (sv) 1999-01-25 1999-01-25 New compounds
EP00902282A EP1155014B1 (en) 1999-01-25 2000-01-24 New benzimidazole compounds for use as active therapeutic substances, process for the preparation of these compoudns and pharmaceutical compositions comprising them
AT00902282T ATE242237T1 (de) 1999-01-25 2000-01-24 Benzimidazolverbindungen zur anwendung als therapeutisch wirksame substanzen, verfahren zur herstellung dieser verbindungen und pharmazeutische zusammensetzungen die diese enthalten
ES00902282T ES2202045T3 (es) 1999-01-25 2000-01-24 Nuevos compuestos de benzimidazol para usar como sustancias terapeuticas activas, procedimiento para la preparacion de estos compuestos y composiciones farmaceuticas que los comprenden.
AU23406/00A AU760346B2 (en) 1999-01-25 2000-01-24 New benzimidazole compounds for use as active therapeutic substances, process for the preparation of these compounds and pharmaceutical compositions comprising them
US09/490,232 US6329383B1 (en) 1999-01-25 2000-01-24 2-amino-5-pyrimidine acetic acid compounds
PT00902282T PT1155014E (pt) 1999-01-25 2000-01-24 Novos compostos de benzimidazol para serem utilizados como substancias terapeuticas activas processi para a preparacao destes compostos e composicoes farmaceuticas que os contem
PCT/SE2000/000144 WO2000043387A1 (en) 1999-01-25 2000-01-24 New benzimidazole compounds for use as active therapeutic substances, process for the preparation of these compoudns and pharmaceutical compositions comprising them
NZ512597A NZ512597A (en) 1999-01-25 2000-01-24 Benzimidazole compounds and their use as active therapeutic substances
SI200030180T SI1155014T1 (en) 1999-01-25 2000-01-24 New benzimidazole compounds for use as active therapeutic substances, process for the preparation of these compoudns and pharmaceutical compositions comprising them
DE60003158T DE60003158T2 (de) 1999-01-25 2000-01-24 Benzimidazolverbindungen zur anwendung als therapeutisch wirksame substanzen, verfahren zur herstellung dieser verbindungen und pharmazeutische zusammensetzungen die diese enthalten
JP2000594803A JP2002535325A (ja) 1999-01-25 2000-01-24 治療用活性物質として使用するための新規ベンゾイミダゾール化合物、これらの化合物の製法およびこれらの化合物を含んでなる薬物組成物
DK00902282T DK1155014T3 (da) 1999-01-25 2000-01-24 Hidtil ukendte benzimidazolforbindelser til anvendelse som aktive, terapeutiske stoffer, fremgangsmåde til fremstilling af disse forbindelser og farmaceutiske sammensætninger omfattende dem
CA002359107A CA2359107A1 (en) 1999-01-25 2000-01-24 New benzimidazole compounds for use as active therapeutic substances, process for the preparation of these compoudns and pharmaceutical compositions comprising them

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9900211A SE9900211D0 (sv) 1999-01-25 1999-01-25 New compounds

Publications (1)

Publication Number Publication Date
SE9900211D0 true SE9900211D0 (sv) 1999-01-25

Family

ID=20414207

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9900211A SE9900211D0 (sv) 1999-01-25 1999-01-25 New compounds

Country Status (12)

Country Link
EP (1) EP1155014B1 (xx)
JP (1) JP2002535325A (xx)
AT (1) ATE242237T1 (xx)
AU (1) AU760346B2 (xx)
CA (1) CA2359107A1 (xx)
DE (1) DE60003158T2 (xx)
DK (1) DK1155014T3 (xx)
ES (1) ES2202045T3 (xx)
NZ (1) NZ512597A (xx)
PT (1) PT1155014E (xx)
SE (1) SE9900211D0 (xx)
WO (1) WO2000043387A1 (xx)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010036613A1 (en) * 2008-09-26 2010-04-01 Merck Sharp & Dohme Corp. Novel cyclic benzimidazole derivatives useful anti-diabetic agents
GB0908394D0 (en) 2009-05-15 2009-06-24 Univ Leuven Kath Novel viral replication inhibitors
GB0913636D0 (en) * 2009-08-05 2009-09-16 Univ Leuven Kath Novel viral replication inhibitors
EP2640705A2 (en) 2010-11-15 2013-09-25 Katholieke Universiteit Leuven Novel antiviral compounds

Also Published As

Publication number Publication date
DE60003158D1 (de) 2003-07-10
AU760346B2 (en) 2003-05-15
JP2002535325A (ja) 2002-10-22
ATE242237T1 (de) 2003-06-15
EP1155014A1 (en) 2001-11-21
DE60003158T2 (de) 2003-12-04
NZ512597A (en) 2003-12-19
WO2000043387A1 (en) 2000-07-27
ES2202045T3 (es) 2004-04-01
AU2340600A (en) 2000-08-07
EP1155014B1 (en) 2003-06-04
CA2359107A1 (en) 2000-07-27
DK1155014T3 (da) 2003-09-29
PT1155014E (pt) 2003-10-31

Similar Documents

Publication Publication Date Title
ATE470662T1 (de) Piperazinylpyrazinverbindungen als agonisten oder antagonisten am serotonin-5ht-2-rezeptor
EA200300595A1 (ru) Соединения пиперазинилпиразинов в качестве антагонистов серотонин 5-ht2 рецептора
EA200301215A1 (ru) Лиганды рецепторов 5-ht и их применение
ATE302775T1 (de) Carbolinderivate
EA199900693A1 (ru) Атропизомеры 3-арил-4(3h)-хиназолинонов и их использование в качестве антагонистов амра-рецепторов
DE60222647D1 (de) Urea derivate als integrin alpha 4 antagonisten
ATE376833T1 (de) Chinazolinon-derivate als vanilloid-antagonisten
ATE260275T1 (de) Substituierte thien-3-yl- sulfonylamino(thio)carbonyl-triazolin(thi)one
EA200300593A1 (ru) Соединения пиперазинилпиразинов в качестве агонистов или антагонистов серотонин 5-ht2 рецептора
ATE346067T1 (de) Carbolinderivate
ATE300543T1 (de) Kondensierte pyrazindionderivate als pde5 inhibitore
HRP20070286T3 (en) Substituted diketopiperazines and their use as oxytocyn antagonists
DK1189900T3 (da) Heterocykliske aminopyrrolidinderivater som melatonerge lægemidler
RS50879B (sr) Kristalna natrijumova so telmisartana i njena primena kao angiotenzinskog antagonista
DE60112960D1 (de) Kondensierte pyridoindolderivate
EA200500830A1 (ru) Производные имидазохинолина в качестве лигандов аденозиновых a3 рецепторов
ATE333457T1 (de) Zyklische gmp-spezifische phosphodiesteraseinhibitoren
SE9900211D0 (sv) New compounds
ATE259813T1 (de) Triazolopyrimidinderivate
CO5271679A1 (es) Inhibidores de proteasa 7-14 miembros
DE60110124D1 (de) Kondensierte pyrazindionderivate als pde inhibitoren
DE60121048D1 (de) PYRAZINOi1'2':1,6öPYRIDOi3,4-BöINDOLDERIVATE
EA200501299A1 (ru) Замещенные производные анилина
CO5160316A1 (es) N-oxidos de las correspondientes bases libres inhibidoras de la fosfodiesterasa iv y su uso para el tratamiento de enfer- medades inflamatorias
EA200400877A1 (ru) 2'-гало-3',5'-диалкоксифен-1'-илимино-2-имидазолидиновые производные и их применение для лечения недержания мочи